DETAX is a specialist for medical polymer materials.
As a specialist in polymer materials, the DETAX group offers its customers a comprehensive product portfolio of dental and otoplastic consumables. Particularly 3D printing materials, an area in which DETAX is a pioneer with an excellent market standing, are experiencing a dynamic development. The group serves an international, broadly diversified and loyal customer base. End users of the products include dental practices, dental laboratories as well as audiologists and audio laboratories. The group operates in a non-cyclical, highly regulated market environment. Complying with such regulation, DETAX holds all relevant MDR certificates. This makes DETAX one of the first companies in the industry with an extensive MDR-certified product portfolio.
An Investor Consortium of PINOVA, ECM and Gilde Healthcare acquired DETAX together with the Management team in January 2022.